ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


  Click here to read this article as a CME activity


Ann Thorac Surg 2008;85:127-133. doi:10.1016/j.athoracsur.2007.07.063
© 2008 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Nicholas G. Smedira
Bruce W. Lytle
Eugene H. Blackstone
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smedira, N. G.
Right arrow Articles by Blackstone, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smedira, N. G.
Right arrow Articles by Blackstone, E. H.
Related Collections
Right arrow Cardiac - other
Right arrowRelated Article


Original Articles: Cardiovascular

Current Effectiveness and Risks of Isolated Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy

Nicholas G. Smedira, MDa,*, Bruce W. Lytle, MDa, Harry M. Lever, MDb, Jeevanantham Rajeswaran, MSc, Gita Krishnaswamy, MSc, Ryan K. Kaple, BSa, Diana O.W. Dolney, MSN, RNb, Eugene H. Blackstone, MDa,c

a Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
b Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
c Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio

Accepted for publication July 20, 2007.

* Address correspondence to Dr Smedira, Kaufman Center for Heart Failure, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, 9500 Euclid Avenue/F24, Cleveland, OH 44195 (Email: smidern{at}ccf.org).

Background: Septal myectomy is the gold-standard therapy for hypertrophic obstructive cardiomyopathy (HOCM). However, it is being challenged by a less-invasive alternative: alcohol septal ablation. This study examined the clinical effectiveness and risks of isolated septal myectomy for HOCM.

Methods: From January 1994 to January 2005, 323 patients underwent isolated septal myectomy (mean age 50 ± 14 years, 53% male). Preoperative septal thickness was 2.3 ± 0.46 cm and peak left ventricular outflow tract (LVOT) gradient 68 ± 43 mm Hg. Effectiveness of myectomy was assessed by echocardiography, sudden death, and functional limitation, early risks by intraoperative and postoperative complications, and late risks by follow-up for HOMC-related reoperation, heart block, and all-cause mortality (mean 3.6 ± 2.8 years, 1,152 patient-years, 10% followed ≥8 years).

Results: Myectomy was effective, resulting in sustained decrease in septal thickness and LVOT gradient, absence of sudden death, and improved functional status. Early in-hospital morbidity was low, with no hospital deaths; two iatrogenic ventricular septal defects were repaired uneventfully, and 22 pacemakers were required for heart block. In the intermediate term, 10 patients required HOCM-related reoperations (4 redo myectomies, 6 mitral valve procedures), with 92% freedom from reoperation at eight years. Seventy-nine percent were free of pacemakers by 8 years, and survival was 90%, equivalent to that of the general population.

Conclusions: Isolated septal myectomy is effective in eliminating LVOT obstruction and sudden death and in improving functional status, with low operative morbidity and mortality. Few reoperations are required late and outcomes are excellent. It should be considered the treatment of choice for HOCM.


Related Article

Invited commentary
Joseph Dearani
Ann. Thorac. Surg. 2008 85: 133-134. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll Cardiol IntvHome page
D. H. Kwon, S. R. Kapadia, E. M. Tuzcu, C. M. Halley, E. Z. Gorodeski, R. J. Curtin, M. Thamilarasan, N. G. Smedira, B. W. Lytle, H. M. Lever, et al.
Long-Term Outcomes in High-Risk Symptomatic Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation
J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 432 - 438.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
U. Sigwart
Catheter Treatment for Hypertrophic Obstructive Cardiomyopathy: For Seniors Only?
Circulation, July 8, 2008; 118(2): 107 - 108.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Dearani
Invited commentary
Ann. Thorac. Surg., January 1, 2008; 85(1): 133 - 134.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.